Finally, four variables were identified as independent predictors of second-line ART treatment failure: poor ART drug adherence, CD4 count < 100cells/mm3 at change, advanced WHO clinical stage and tuberculosis co-infection. The gene discussed is CD4; the disease is tuberculosis.